| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
( Department of Pharmacology, Yale University School of Medicine, New Haven, Conn.)
5-Iododeoxyuridine inhibited the utilization of radioactive orotic acid, formate, and thymidine for the biosynthesis of DNA-thymine, but not of orotic acid for the biosynthesis of DNA-cytosine or of RNA-pyrimidines, by mouse Ehrlich ascites tumor cells in vitro. The analog was a competitive antagonist of thymidine in this system; however, in view of the incorporation of the iodo-compound into DNA in place of thymidine, the site of inhibition probably occurs at either the monophosphate or triphosphate level.
* This investigation was supported by a grant (CY-3076) from the National Institutes of Health, U.S. Public Health Service.
Received 7/13/59.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |